Table 1.
Laboratory findings of control subjects and IBD patients enrolled in the study.
| Parameters (unit) | Control | CD | UC |
|---|---|---|---|
| White blood cell (G/L) | 8.6 ± 0.2 | 9.1 ± 1.1 | 8.4 ± 0.8 |
| Neutrophil (G/L) | 5.9 ± 0.2 | 6.9 ± 1.1 | 5.4 ± 0.6 |
| Lymphocyte (G/L) | 1.8 ± 0.3 | 1.4 ± 0.1 | 1.8 ± 0.2 |
| Monocyte (G/L) | 0.8 ± 0.6 | 1.0 ± 0.4 | 0.7 ± 0.1 |
| Eosinophil (G/L) | 0.18 ± 0.01 | 0.14 ± 0.02 | 0.14 ± 0.03 |
| Basophil (G/L) | 0.05 ± 0.01 | 0.03 ± 0.01 | 0.05 ± 0.02 |
| Red blood cell (T/L) | 4.4 ± 0.3 | 4.3 ± 0.1 | 4.3 ± 0.1 |
| Hemoglobin (g/dL) | 13.9 ± 0.4 | 12.7 ± 0.3 | 12.7 ± 0.3 |
| Sodium (mmol/dL) | 139.6 ± 4.0 | 137.6 ± 0.5 | 137.0 ± 1.5 |
| Potassium (mmol/dL) | 4.3 ± 0.2 | 4.0 ± 0.1 | 4.0 ± 0.1 |
| C-reactive protein (CRP; mg/dL) | 1.1 ± 0.2 | 31.8 ± 9.1 ** | 35.4 ± 11.3 *** |
Values presented as a means ± SEM; ** P <0.01, *** P <0.001 vs. control.